KRT5, Human Antibody from NKMAX Co. Ltd.

Search, find, compare suppliers for anti-KRT5, Human antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityKRT5, Human
CloneAT12C4
Host SpeciesMouse
Reactive Specieshuman
IsotypeIgG2a kappa
FormatProtein A purified
Size50ul, 100ul
Concentration1mg/ml (determined by BCA assay)
ApplicationsELISA,WB,ICC/IF,IHC,FACS
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionKeratin 5, also known as KRT5, K5, or CK5, dimerizes with keratin 14 and forms the intermediate filaments (IF) that make up the cytoskeleton of basal epithelial cells. This protein is involved in several diseases including epidermolysis bullosa simplex and breast and lung cancers. Keratin 5 (and K14) are expressed primarily in basal keratinocytes in the epidermis, specifically in the stratified epithelium lining the skin and digestive tract. Keratin intermediate filaments make up the cytoskeletal scaffold within epithelial cells, which contributes to the cell architecture and provides the cells with the ability to withstand mechanical, and non-mechanical, stresses. K5/K14 keratin pairs are able to undergo extensive bundling due to the non-helical tail of K15 acting as a weak cross-linker at the intermediate filament surface. This bundling increase the elasticity, and therefore the mechanical resilience, of the intermediate filaments.
ImmunogenRecombinant human KRT5 (1-590aa) purified from E. coli
Other NamesKeratin 5, CK5, DDD, K5, KRT5A
Gene, Accession #NCBI: NP_000415, UniProt: P13647
Catalog #ATGA0368
Price$170, $290
Order / More InfoKRT5, Human Antibody from NKMAX Co. Ltd.
Product Specific Referencesn/a
NKMAX Co. Ltd.
NKMAX Co. Ltd.
NKMAX Co. Ltd.
6F, SNUH Health Care Innovation Park
172 Dolma-ro, Bundang-gu
Seongnam-si, Gyeonggi-do 13605 REPUBLIC OF KOREA
P: +82-31-8017-8114
F: +82-31-8017-8124

salesbio@nkmax.com

http://www.nkmaxbio.com

Profile of NKMAX Co. Ltd.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.